Wells Fargo Maintains Overweight on Eli Lilly, Raises Price Target to $1500

Benzinga · 3d ago
Wells Fargo analyst Mohit Bansal maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1330 to $1500.